Alnylam Pharmaceuticals (ALNY) Gross Margin (QoQ) (2018 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Revolution Medicines | 32.39 Bn | 32.39 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 662.00 |
| Dec 31, 2025 | -861.00 |
| Sep 30, 2025 | 257.00 |
| Jun 30, 2025 | 21,559.00 |
| Mar 31, 2025 | -21,664.00 |
| Dec 31, 2024 | -94.00 |
| Sep 30, 2024 | -617.00 |
| Jun 30, 2024 | 85.00 |
| Mar 31, 2024 | 532.00 |
| Dec 31, 2023 | -578.00 |
| Sep 30, 2023 | 1,305.00 |
| Jun 30, 2023 | -1,066.00 |
| Mar 31, 2023 | 80.00 |
| Dec 31, 2022 | 3.00 |
| Sep 30, 2022 | 133.00 |
| Jun 30, 2022 | -414.00 |
| Mar 31, 2022 | 201.00 |
| Dec 31, 2021 | 196.00 |
| Sep 30, 2021 | -125.00 |
| Jun 30, 2021 | -75.00 |
| Mar 31, 2021 | 36.00 |
| Dec 31, 2020 | 322.00 |
| Sep 30, 2020 | 102.00 |
| Jun 30, 2020 | -420.00 |
| Mar 31, 2020 | 361.00 |
| Dec 31, 2019 | -955.00 |
| Sep 30, 2019 | 223.00 |
| Jun 30, 2019 | 38.00 |
| Mar 31, 2019 | -214.00 |
| Dec 31, 2018 | -129.00 |